Literature DB >> 14583870

Incident hepatitis C virus in women with human immunodeficiency virus infection.

M Augenbraun1, J J Goedert, D Thomas, J Feldman, E C Seaberg, A L French, E Robison, M Nowicki, N Terrault.   

Abstract

Individuals infected with human immunodeficiency virus type 1 (HIV-1) are frequently coinfected with hepatitis C virus (HCV). Acute HCV infection is often asymptomatic and poorly understood. We conducted a historical prospective study of HCV antibody and viremia in plasma samples obtained during 1994-1999 from a cohort of initially HIV-1-infected, HCV-uninfected women and from HIV-1-HCV-uninfected women. Twenty-two (1.5%) of 1517 experienced seroconversion. Of these, 14 (64%) truly acquired a new infection as assessed by enzyme immunoassay response and new-onset viremia. The incidence rate in HIV-1-infected women was 2.7 cases per 1000 person-years; it was 3.3 cases per 1000 person-years in HIV-1-seronegative women (relative risk, 1.21; P=.75). Acquisition of HCV was associated with any history of drug use (P<.01). Five of 12 viremic, seroconverting individuals cleared viremia. Incident HCV infection among HIV-1-infected and HIV-1-uninfected women was low. It was linked to drug use and commonly resolved.

Entities:  

Mesh:

Year:  2003        PMID: 14583870     DOI: 10.1086/379075

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 2.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 3.  Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

4.  Awareness of hepatitis C infection among women with and at risk for HIV.

Authors:  Mardge H Cohen; Dennis Grey; Judith A Cook; Kathryn Anastos; Eric Seaberg; Michael Augenbraun; Pam Burian; Marion Peters; Mary Young; Audrey French
Journal:  J Gen Intern Med       Date:  2007-10-09       Impact factor: 5.128

5.  Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.

Authors:  Audrey L French; Michael Y Lin; Charlesnika T Evans; Lorie Benning; Marshall J Glesby; Mary A Young; Eva A Operskalski; Michael Augenbraun; Marion Peters
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

6.  Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.

Authors:  Monika Sarkar; Peter Bacchetti; Phyllis Tien; Elizabeth Mileti; Audrey L French; Brian R Edlin; Marla Keller; Eric Seaberg; Marek J Nowicki; Mary Young; Marion G Peters
Journal:  Dig Dis Sci       Date:  2012-11-24       Impact factor: 3.199

7.  Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan.

Authors:  Sobia Kanwal; Tariq Mahmood
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

8.  Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.

Authors:  Peter Bacchetti; Phyllis C Tien; Eric C Seaberg; Thomas R O'Brien; Michael H Augenbraun; Alex H Kral; Michael P Busch; Brian R Edlin
Journal:  BMC Infect Dis       Date:  2007-12-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.